Pfizer seeks FDA emergency use authorization for its antiviral pill, which the company says reduces the risk of Covid-19 hospitalization and death
Antiviral pills for Covid-19 -- not a cure, but a great tool"With more than 5 million deaths and countless lives impacted by this devastating disease globally, there is an urgent need for life-saving treatment options.
Pfizer says it is investing up to approximately $1 billion into the manufacturing and distribution of this treatment and also has rolling submissions for the pill in other countries including the UK, Australia, New Zealand and South Korea.Read MoreMerck and Ridgeback Biotherapeutics are also seeking FDA emergency use authorization an antiviral pill known as molnupiravir; an FDA advisory committee is scheduled to meet on November 30 to discuss the application.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Pfizer Seeks FDA Emergency Use Authorization for Its COVID-19 PillPfizer has signed a deal to allow other manufacturers to make its experimental COVID-19 pill, possibly opening up access to treatment to countries across the world:
Les mer »
Covid-19: Booster jabs for over-40s and Northern Ireland considers Covid passportsFive things you need to know about the coronavirus pandemic this Monday evening.
Les mer »
U.S. expected to purchase 10 million courses of Pfizer COVID-19 pill - WaPoEarlier this month, Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, said the pill https://reut.rs/3oxaxnz cut the chance of hospitalization or death for adults at risk of severe disease by 89% in its clinical trial. Pfizer expects to submit interim trial results for the pill, branded Paxlovid, to the Food and Drug Administration (FDA) before the Nov. 25 U.S. Thanksgiving holiday.
Les mer »
Pfizer asks US officials to OK promising COVID-19 pillWASHINGTON (AP) — Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks.
Les mer »
Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
Les mer »